| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 133, 397-406, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
RV Lloyd, M Cano and TD Landefeld
Department of Pathology, University of Michigan Medical School, Ann Arbor.
Estrogens inhibit tumor growth and modify PRL and GH expression in the MtT/W15 transplantable rat pituitary tumor. The effects of estradiol (E2) and diethylstilbestrol (DES) on PRL and GH mRNA levels were investigated. Estrogens increased GH mRNA levels and decreased PRL mRNA levels as detected by in situ hybridization and Northern blot hybridization with oligonucleotide probes, while inhibiting tumor growth. Similar changes in immunoreactive GH and PRL were seen in the tumor cells. The pituitary glands of tumor-bearing rats treated with estrogen for 3 weeks were increased in weight with a concurrent increase in pituitary PRL mRNA when analyzed by dot blot hybridization. These results indicate that estrogens have an inhibitory effect on the growth of the MtT/W15 tumor and increase GH protein and mRNA levels, while causing PRL protein and mRNA levels to decrease. The pituitaries of tumor-bearing rats concomitantly undergo PRL cell hyperplasia with an increase in PRL mRNA. These results also demonstrate a paradoxical effect of estrogens on different pituitary tissues.
This article has been cited by other articles:
 |
|
 |
|
  X. Zhu, S. L. Asa, and S. Ezzat Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia Clin. Cancer Res., April 1, 2008; 14(7): 1984 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Adamson, S. Friedrichsen, S. Semprini, C. V. Harper, J. J. Mullins, M. R. H. White, and J. R. E. Davis Human Prolactin Gene Promoter Regulation by Estrogen: Convergence with Tumor Necrosis Factor-{alpha} Signaling Endocrinology, February 1, 2008; 149(2): 687 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Luque and R. D. Kineman Gender-Dependent Role of Endogenous Somatostatin in Regulating Growth Hormone-Axis Function in Mice Endocrinology, December 1, 2007; 148(12): 5998 - 6006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. WYNICK, C. J. SMALL, S. R. BLOOM, and V. PACHNIS Targeted Disruption of the Murine Galanin Gene Ann. N.Y. Acad. Sci., December 21, 1998; 863(1): 22 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. E. McKeever Insights About Brain Tumors Gained Through Immunohistochemistry and in Situ Hybridization of Nuclear and Phenotypic Markers J. Histochem. Cytochem., May 1, 1998; 46(5): 585 - 594. [Abstract] [Full Text]
|
|
|
|
|
|
A. Matsuno, S. Takekoshi, N. Sanno, H. Utsunomiya, Y. Ohsugi, N. Saito, H. Kanemitsu, A. Tamura, T. Nagashima, R. Y. Osamura, et al. Modulation of Protein Kinases and Microtubule-associated Proteins and Changes in Ultrastructure in Female Rat Pituitary Cells: Effects of Estrogen and Bromocriptine J. Histochem. Cytochem., January 1, 1997; 45(6): 805 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gharaee-Kermani, E. M. Denholm, and S. H. Phan Costimulation of Fibroblast Collagen and Transforming Growth Factor beta 1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors J. Biol. Chem., July 26, 1996; 271(30): 17779 - 17784. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
